Q1 2019 Holdings
Filed 2019-05-14 | 21 holdings | $94.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ascendis Pharma A/S(ASND) | COM | 04351P101 | $59.3M | 504,210 | 63.0% |
| BioCryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $26.4M | 3,249,164 | 28.1% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $8.1M | 571,956 | 8.6% |
| Biohaven Pharmaceuticals(BHVN) | COM | G11196105 | $58.6K | 1,138,075 | 0.1% |
| Tricida Inc(1T7) | COM | 89610F101 | $37.2K | 962,695 | 0.0% |
| Shockwave Medical Inc(SWAVUSD) | COM | 82489T104 | $30.2K | 901,256 | 0.0% |
| Obseva SA | COM | H5861P103 | $28.8K | 2,252,460 | 0.0% |
| Zogenix | COM | 98978L204 | $19.9K | 362,010 | 0.0% |
| Kalvista Pharmaceuticals(KALV) | COM | 483497103 | $16.4K | 573,482 | 0.0% |
| Ra Pharmaceuticals | COM | 74933V108 | $14.2K | 632,480 | 0.0% |
| Kiniksa Pharmaceuticals Ltd | COM | G5269C101 | $11.5K | 639,230 | 0.0% |
| Constellation Pharmaceuticals(CNST) | COM | 210373106 | $9.8K | 726,677 | 0.0% |
| Spero Therapeutics Inc(SPRO) | COM | 84833T103 | $6.1K | 474,015 | 0.0% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $3.4K | 271,377 | 0.0% |
| Marinus Pharmaceuticals Inc | COM | 56854Q101 | $3.1K | 743,876 | 0.0% |
| Bellerophon Therapeutics(BLPHEUR) | COM | 078771102 | $2.7K | 4,149,378 | 0.0% |
| La Jolla Pharmaceuticals(LJPC) | COM | 503459604 | $2.4K | 371,400 | 0.0% |
| Kadmon Holdings Inc.(KDMN) | COM | 48283N106 | $2.2K | 820,123 | 0.0% |
| Gemphire Therapeutics | COM | 36870A108 | $591 | 513,752 | 0.0% |
| Proteostasis Therapeutics Inc | COM | 74373B109 | $538 | 427,110 | 0.0% |
| Orchard RX Ltd | COM | 68570P101 | $221 | 12,383 | 0.0% |